Search

Start Over Creator Šafránek, Roman

1. Denosumab associated with bone density increase and clinical improvement in a long-term hemodialysis patient. Case report and review of the literature

Creator:
Sulková, Sylvie, Horáček, Jiří, Šafránek, Roman, Gorun, Petr, Viklický, Ondřej, and Palička, Vladimír
Format:
print, text, and regular print
Type:
model:article, article, Text, kazuistiky, časopisecké články, práce podpořená grantem, přehledy, and TEXT
Subject:
dospělí, monoklonální protilátky humanizované--aplikace a dávkování--škodlivé účinky, kostní denzita, inhibitory kostní resorpce--aplikace a dávkování--škodlivé účinky, ženské pohlaví, lidé, chronické selhání ledvin--komplikace--terapie, osteoporóza--komplikace--farmakoterapie, and hemodialýza
Language:
English
Description:
Denosumab is a human monoclonal antibody representing a novel therapy of osteoporosis. Contrary to always other antiosteoporotic drugs, it is not contraindicated in advanced chronic kidney disease, as its pharmacokinetic does not differ from patients with normal kidney function. However, published case reports in chronic kidney disease (CKD) patients stopped the therapy after single dose because of hypocalcemia. We present a case of successful treatment of osteoporosis in a young hemodialysis patient with repeated denosumab doses. and Sylvie Dusilová Sulková, Jiří Horáček, Roman Šafránek, Petr Gorun, Ondřej Viklický, Vladimír Palička
Rights:
http://creativecommons.org/publicdomain/mark/1.0/ and policy:public